These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9340935)

  • 1. [Does fecal occult blood screening result in decreased mortality from large intestine cancer?].
    Porschen R; Haack G
    Z Gastroenterol; 1997 Jul; 35(7):595-6. PubMed ID: 9340935
    [No Abstract]   [Full Text] [Related]  

  • 2. [Does yearly fecal exam for occult blood lower colorectal cancer mortality?].
    Gerbes L; Jüngst D; Köbberling J
    Z Gastroenterol; 1994 Oct; 32(10):603-6. PubMed ID: 7716998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fecal blood screening lowers mortality from intestinal cancer].
    Gnauck R
    Leber Magen Darm; 1994 Mar; 24(2):55-6. PubMed ID: 8196465
    [No Abstract]   [Full Text] [Related]  

  • 4. [Annual occult blood tests lower intestinal cancer mortality].
    Gnauck R
    Wien Med Wochenschr; 1993; 143(13):352. PubMed ID: 8237026
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of colorectal carcinoma. Annual hemoccult test and sigmoidoscopy every 5 years].
    Rosenbaum A; Riemann JF
    MMW Fortschr Med; 2000 Aug; 142(31-32):27-9. PubMed ID: 10992763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal-occult-blood test screening for colorectal cancer.
    Zacks M
    J Fam Pract; 1997 Mar; 44(3):247-8. PubMed ID: 9071239
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for prevention of colorectal carcinoma. Who, when, how?].
    Kolligs FT; Sackmann M; Göke B
    MMW Fortschr Med; 2002 Dec; 144(51-52):24-8. PubMed ID: 12596679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer mortality in two areas of Tuscany with different screening exposures.
    Costantini AS; Martini A; Puliti D; Ciatto S; Castiglione G; Grazzini G; Zappa M
    J Natl Cancer Inst; 2008 Dec; 100(24):1818-21. PubMed ID: 19066268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology and screening of colorectal cancer].
    Dancourt V; Faivre J
    Rev Prat; 2004 Jan; 54(2):135-42. PubMed ID: 15086055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in colorectal cancer mortality related to annual fecal occult blood screening--13 year follow-up of 46,000 subjects.
    Kita MW
    J Insur Med; 1993; 25(2):138-9. PubMed ID: 10146315
    [No Abstract]   [Full Text] [Related]  

  • 14. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 16. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mass screening for colorectal cancer using occult blood studies. From theoretic efficacy to generalized practice].
    Launoy G; Herbert C
    Rev Epidemiol Sante Publique; 1997 Apr; 45(2):177-8. PubMed ID: 9221447
    [No Abstract]   [Full Text] [Related]  

  • 18. [Test for occult blood in feces: a method for reducing the mortality from colorectal cancer?].
    Faivre J; Tazi MA
    Gastroenterol Clin Biol; 1996; 20(3):225-7. PubMed ID: 8763058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology of colorectal cancer].
    Becker N
    Radiologe; 2003 Feb; 43(2):98-104. PubMed ID: 12624666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.